Low-dose cyclosporin therapy for recombinant erythropoietin-induced pure red-cell aplasia

Nephrol Dial Transplant. 2004 Feb;19(2):479-81. doi: 10.1093/ndt/gfg535.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Cyclosporine / administration & dosage*
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Erythropoietin / adverse effects*
  • Erythropoietin / therapeutic use
  • Female
  • Follow-Up Studies
  • Humans
  • Kidney Failure, Chronic / diagnosis
  • Kidney Failure, Chronic / therapy
  • Middle Aged
  • Recombinant Proteins
  • Red-Cell Aplasia, Pure / chemically induced*
  • Red-Cell Aplasia, Pure / drug therapy*
  • Risk Assessment
  • Treatment Outcome

Substances

  • Recombinant Proteins
  • Erythropoietin
  • Cyclosporine